| Record Information |
|---|
| Version | 5.0 |
|---|
| Status | Detected but not Quantified |
|---|
| Creation Date | 2021-09-10 21:11:26 UTC |
|---|
| Update Date | 2021-09-26 22:51:24 UTC |
|---|
| HMDB ID | HMDB0243984 |
|---|
| Secondary Accession Numbers | None |
|---|
| Metabolite Identification |
|---|
| Common Name | 1-Oxoestazolam |
|---|
| Description | 1-Oxoestazolam belongs to the class of organic compounds known as 1,4-benzodiazepines. These are organic compounds containing a benzene ring fused to a 1,4-azepine. Based on a literature review very few articles have been published on 1-Oxoestazolam. This compound has been identified in human blood as reported by (PMID: 31557052 ). 1-oxoestazolam is not a naturally occurring metabolite and is only found in those individuals exposed to this compound or its derivatives. Technically 1-Oxoestazolam is part of the human exposome. The exposome can be defined as the collection of all the exposures of an individual in a lifetime and how those exposures relate to health. An individual's exposure begins before birth and includes insults from environmental and occupational sources. |
|---|
| Structure | ClC1=CC2=C(C=C1)N1C(=O)NN=C1CN=C2C1=CC=CC=C1 InChI=1S/C16H11ClN4O/c17-11-6-7-13-12(8-11)15(10-4-2-1-3-5-10)18-9-14-19-20-16(22)21(13)14/h1-8H,9H2,(H,20,22) |
|---|
| Synonyms | | Value | Source |
|---|
| 1-Ketoestazolam | HMDB | | 1-oxo-Estazolam | HMDB |
|
|---|
| Chemical Formula | C16H11ClN4O |
|---|
| Average Molecular Weight | 310.74 |
|---|
| Monoisotopic Molecular Weight | 310.0621387 |
|---|
| IUPAC Name | 12-chloro-9-phenyl-2,4,5,8-tetraazatricyclo[8.4.0.0^{2,6}]tetradeca-1(10),5,8,11,13-pentaen-3-one |
|---|
| Traditional Name | 12-chloro-9-phenyl-2,4,5,8-tetraazatricyclo[8.4.0.0^{2,6}]tetradeca-1(10),5,8,11,13-pentaen-3-one |
|---|
| CAS Registry Number | Not Available |
|---|
| SMILES | ClC1=CC2=C(C=C1)N1C(=O)NN=C1CN=C2C1=CC=CC=C1 |
|---|
| InChI Identifier | InChI=1S/C16H11ClN4O/c17-11-6-7-13-12(8-11)15(10-4-2-1-3-5-10)18-9-14-19-20-16(22)21(13)14/h1-8H,9H2,(H,20,22) |
|---|
| InChI Key | BKXMIHOSZZYXDH-UHFFFAOYSA-N |
|---|
| Chemical Taxonomy |
|---|
| Description | Belongs to the class of organic compounds known as 1,4-benzodiazepines. These are organic compounds containing a benzene ring fused to a 1,4-azepine. |
|---|
| Kingdom | Organic compounds |
|---|
| Super Class | Organoheterocyclic compounds |
|---|
| Class | Benzodiazepines |
|---|
| Sub Class | 1,4-benzodiazepines |
|---|
| Direct Parent | 1,4-benzodiazepines |
|---|
| Alternative Parents | |
|---|
| Substituents | - 1,4-benzodiazepine
- Aryl chloride
- Aryl halide
- Monocyclic benzene moiety
- Benzenoid
- Azole
- Heteroaromatic compound
- 1,2,4-triazole
- Ketimine
- Azacycle
- Organic 1,3-dipolar compound
- Propargyl-type 1,3-dipolar organic compound
- Organonitrogen compound
- Organochloride
- Organohalogen compound
- Imine
- Hydrocarbon derivative
- Organic oxide
- Organooxygen compound
- Organic nitrogen compound
- Organic oxygen compound
- Aromatic heteropolycyclic compound
|
|---|
| Molecular Framework | Aromatic heteropolycyclic compounds |
|---|
| External Descriptors | Not Available |
|---|
| Ontology |
|---|
| Physiological effect | Not Available |
|---|
| Disposition | |
|---|
| Process | Not Available |
|---|
| Role | Not Available |
|---|
| Physical Properties |
|---|
| State | Not Available |
|---|
| Experimental Molecular Properties | | Property | Value | Reference |
|---|
| Melting Point | Not Available | Not Available | | Boiling Point | Not Available | Not Available | | Water Solubility | Not Available | Not Available | | LogP | Not Available | Not Available |
|
|---|
| Experimental Chromatographic Properties | Not Available |
|---|
| Predicted Molecular Properties | |
|---|
| Predicted Chromatographic Properties | Predicted Collision Cross SectionsPredicted Retention Times Underivatized| Chromatographic Method | Retention Time | Reference |
|---|
| Predicted by Siyang on May 30, 2022 | 11.6532 minutes | 33406817 | | Predicted by Siyang using ReTip algorithm on June 8, 2022 | 1.39 minutes | 32390414 | | Fem_Long = Waters ACQUITY UPLC HSS T3 C18 with Water:MeOH and 0.1% Formic Acid | 1498.7 seconds | 40023050 | | Fem_Lipids = Ascentis Express C18 with (60:40 water:ACN):(90:10 IPA:ACN) and 10mM NH4COOH + 0.1% Formic Acid | 316.1 seconds | 40023050 | | Life_Old = Waters ACQUITY UPLC BEH C18 with Water:(20:80 acetone:ACN) and 0.1% Formic Acid | 150.6 seconds | 40023050 | | Life_New = RP Waters ACQUITY UPLC HSS T3 C18 with Water:(30:70 MeOH:ACN) and 0.1% Formic Acid | 193.1 seconds | 40023050 | | RIKEN = Waters ACQUITY UPLC BEH C18 with Water:ACN and 0.1% Formic Acid | 145.6 seconds | 40023050 | | Eawag_XBridgeC18 = XBridge C18 3.5u 2.1x50 mm with Water:MeOH and 0.1% Formic Acid | 396.6 seconds | 40023050 | | BfG_NTS_RP1 =Agilent Zorbax Eclipse Plus C18 (2.1 mm x 150 mm, 3.5 um) with Water:ACN and 0.1% Formic Acid | 411.7 seconds | 40023050 | | HILIC_BDD_2 = Merck SeQuant ZIC-HILIC with ACN(0.1% formic acid):water(16 mM ammonium formate) | 115.1 seconds | 40023050 | | UniToyama_Atlantis = RP Waters Atlantis T3 (2.1 x 150 mm, 5 um) with ACN:Water and 0.1% Formic Acid | 983.4 seconds | 40023050 | | BDD_C18 = Hypersil Gold 1.9µm C18 with Water:ACN and 0.1% Formic Acid | 407.0 seconds | 40023050 | | UFZ_Phenomenex = Kinetex Core-Shell C18 2.6 um, 3.0 x 100 mm, Phenomenex with Water:MeOH and 0.1% Formic Acid | 1050.7 seconds | 40023050 | | SNU_RIKEN_POS = Waters ACQUITY UPLC BEH C18 with Water:ACN and 0.1% Formic Acid | 293.3 seconds | 40023050 | | RPMMFDA = Waters ACQUITY UPLC BEH C18 with Water:ACN and 0.1% Formic Acid | 329.0 seconds | 40023050 | | MTBLS87 = Merck SeQuant ZIC-pHILIC column with ACN:Water and :ammonium carbonate | 301.0 seconds | 40023050 | | KI_GIAR_zic_HILIC_pH2_7 = Merck SeQuant ZIC-HILIC with ACN:Water and 0.1% FA | 144.1 seconds | 40023050 | | Meister zic-pHILIC pH9.3 = Merck SeQuant ZIC-pHILIC column with ACN:Water 5mM NH4Ac pH9.3 and 5mM ammonium acetate in water | 18.6 seconds | 40023050 |
Predicted Kovats Retention IndicesUnderivatizedDerivatized| Derivative Name / Structure | SMILES | Kovats RI Value | Column Type | Reference |
|---|
| 1-Oxoestazolam,1TMS,isomer #1 | C[Si](C)(C)N1N=C2CN=C(C3=CC=CC=C3)C3=CC(Cl)=CC=C3N2C1=O | 2924.9 | Semi standard non polar | 33892256 | | 1-Oxoestazolam,1TMS,isomer #1 | C[Si](C)(C)N1N=C2CN=C(C3=CC=CC=C3)C3=CC(Cl)=CC=C3N2C1=O | 2830.9 | Standard non polar | 33892256 | | 1-Oxoestazolam,1TMS,isomer #1 | C[Si](C)(C)N1N=C2CN=C(C3=CC=CC=C3)C3=CC(Cl)=CC=C3N2C1=O | 4091.1 | Standard polar | 33892256 | | 1-Oxoestazolam,1TBDMS,isomer #1 | CC(C)(C)[Si](C)(C)N1N=C2CN=C(C3=CC=CC=C3)C3=CC(Cl)=CC=C3N2C1=O | 3104.4 | Semi standard non polar | 33892256 | | 1-Oxoestazolam,1TBDMS,isomer #1 | CC(C)(C)[Si](C)(C)N1N=C2CN=C(C3=CC=CC=C3)C3=CC(Cl)=CC=C3N2C1=O | 3021.4 | Standard non polar | 33892256 | | 1-Oxoestazolam,1TBDMS,isomer #1 | CC(C)(C)[Si](C)(C)N1N=C2CN=C(C3=CC=CC=C3)C3=CC(Cl)=CC=C3N2C1=O | 4072.8 | Standard polar | 33892256 |
|
|---|